Medidata Sees Strong Momentum with Key Customer Wins, Advances in CNS and Digital Therapeutics, and Expanded Market Leadership

Core Insights - Medidata is advancing the life sciences industry through innovative, AI-powered solutions and a focus on patient, data, and study experiences [1][5][6] Group 1: Innovation and Partnerships - Medidata has launched the Site Insights Program to enhance site engagement and technology compliance in research [3] - The company has partnered with Cogstate to develop a comprehensive CNS trial experience, optimizing endpoint data quality [4] - Collaborations with Click Therapeutics aim to support patients beyond clinical trials with software-enhanced drugs [4][5] Group 2: Market Leadership - Medidata secured new enterprise agreements with a large pharmaceutical company, two top 10 biopharma manufacturers, and ICON, reinforcing its position as a trusted partner in clinical trials [5] - The company continues to set industry standards in clinical trial innovation, leveraging AI and machine learning to accelerate drug development [5] Group 3: Recognition and Awards - Medidata's Clinical Data Studio was recognized for improving data quality and accelerating study timelines, earning accolades from the Summit for Clinical Ops Executives [6] - The company was inducted into the Digital Health New York Hall of Fame, highlighting its commitment to innovation [6] - Medidata received the 2025 MedTech Breakthrough Award for Best Clinical Trial Technology Solution Provider due to its collaboration with Cogstate [6] Group 4: Leadership Strengthening - Medidata has enhanced its leadership team with new executive appointments and promotions to drive patient-centered innovation [7]